GlassScriptPhysician profile
Keith W Brantley
NPI 1609852672
$3,185.99
in general payments reported to CMS, 2019-2025
33 companies · $224 in 2025
The $224 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $453 · 2020: $226 · 2021: $330 · 2022: $446 · 2023: $632 · 2024: $875 · 2025: $224.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,631 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,631.01 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $505.03 | 2019-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $414.04 | 2019-2024 | Brilinta, Farxiga |
| Boston Scientific Corporation | $315.58 | 2020-2024 | Watchman Flx, Watchman Access System |
| Pfizer INC. | $299.45 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $245.45 | 2020-2025 | |
| Janssen Pharmaceuticals, INC | $164.89 | 2020-2023 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $157.31 | 2019-2025 | Eliquis, Camzyos |
| Abiomed | $150.89 | 2021-2024 | Impella |
| Regeneron Healthcare Solutions, INC. | $113.24 | 2019 | |
| Edwards Lifesciences Corporation | $82.10 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Pascal |
| Sanofi-Aventis U.S. LLC | $80.96 | 2019-2023 | |
| Novo Nordisk INC | $78.94 | 2023-2025 | Ozempic, Wegovy |
| Atricure, INC. | $53.96 | 2023 | |
| Actelion Pharmaceuticals US, INC. | $50.74 | 2022-2024 | Uptravi, Opsumit |
| Kiniksa Pharmaceuticals International, Plc | $50.39 | 2024 | Arcalyst |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $37.22 | 2019-2020 | |
| Cardiovascular Systems INC. | $36.83 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $35.66 | 2023-2024 | |
| American Regent | $32.83 | 2023-2024 | Injectafer |
| Esperion Therapeutics, INC. | $30.89 | 2020-2025 | Nexletol |
| Amarin Pharma, INC. | $28.71 | 2019-2022 | |
| Terumo Medical Corporation | $27.42 | 2022 | |
| Becton, Dickinson and Company | $24.63 | 2024 | Rotarexs 6 F X 135 Cm |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.72 | 2019 | |
| Abbott Laboratories | $23.27 | 2024 | Mitraclip |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $17.32 | 2022 | |
| Silk Road Medical, INC. | $16.82 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Medtronic, INC. | $16.13 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $15.83 | 2023 | Inpefa |
| W. L. Gore & Associates, INC. | $15.09 | 2025 | Gore Cardioform Septal Occluder |
| Kowa Pharmaceuticals America, INC. | $14.68 | 2020 | |
| Cvrx, INC. | $14.67 | 2025 | Barostim Neo System |
| Intact Vascular, INC. | $11.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Brantley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.